Understanding antimicrobial resistance to manage cholera

  02 October 2023

Genomic epidemiology of the Yemen cholera outbreak reveals the genetic basis for emergence of multidrug resistance with implications for Vibrio cholerae surveillance and control.

Within a decade of its initial spread from the Bay of Bengal, 7PET V. cholerae reached Pakistan and Africa, then disseminated to Latin America in the 1990s, Haiti in 2010 and Yemen in 2016. Among these occurrences, the largest is taking place in Yemen. Genomic epidemiology revealed that the 7PET T13 sublineage circulating in Yemen was seeded by a single transmission originating in South Asia to Yemen, and it was susceptible to all antibiotics. Subsequent surveillance unveiled a troubling development that Yemeni V. cholerae strains isolated in late 2018 had acquired multidrug resistance. 

Further reading: Nature Microbiology
Author(s): Agila Kumari Pragasam, Veeraraghavan Balaji & Ankur Mutreja
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed